if you like peptides you're going to love when we find the p | Beau Deblieck Fd62 on Binance Square

Trending Articles

Bookmarked and Liked

Beau Deblieck Fd62

--

if you like peptides you're going to love when we find the peptide that inhibits the peptide that inhibits INMT so you can produce endogenous DMT

Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.

51

0

Explore the latest crypto news

⚡️ Be a part of the latests discussions in crypto

💬 Interact with your favorite creators

👍 Enjoy content that interests you

Email / Phone number

Relevant Creator

Beau Deblieck Fd62

@Square-Creator-ecd32469e5df8

Explore More From Creator

attn: $PSYC hodlers. dive deep. weekly jam sesh starts now. eDMT, dev, AI, Amazonian botanicals, and more. https://discord.com/events/898139202594668585/1378030749810167968/1397941390540800000

--

put it in your brain

--

🚨BREAKING: $PSY Holders Vote to Fund Research into Endogenous DMT Biosynthesis 🚨 PsyDAO to partner with leading researchers and institutions Asking❓is there DMT in our bodies? how is it made and broken down? can we dial it up and down? 💊 Vote totals here: https://t.co/KdtFu5lc8E @alieninsect @noonautics @UFHealth

--

* DMT voting ends July 19 at 14:20 MT / 22:20 CET $PSY hodlers take note ... and vote. https://snapshot.box/#/s:psydao.eth/proposal/0x4d58953af32e929b877b01119b621c73d0092a7560f8a130062ec008ad2fe94b/votes

--

DMT entities can't vote on funding DMT research 👾 So $PSY hodlers have to Polls close Friday at 14:20 MDT / 22:20 CEST https://snapshot.box/#/s:psydao.eth/proposal/0x4d58953af32e929b877b01119b621c73d0092a7560f8a130062ec008ad2fe94b

--

Latest News

Bitcoin(BTC) Surpasses 119,000 USDT with a 0.88% Increase in 24 Hours

--

Ethereum(ETH) Surpasses 3,700 USDT with a 3.22% Increase in 24 Hours

--

TRON Inc. Celebrates Nasdaq Rebranding with Justin Sun's Participation

--

Bitmine Immersion Expands ATM Program to $4.5 Billion

--

Stablecoin Supply Expected to Surge Following GENIUS Act Passage

--

Cookie Preferences

Cookie Preferences